Tianjin Lisheng Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000NJ9
CNY
20.33
-0.18 (-0.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,312.79
1,130.16
1,122.48
1,069.50
1,117.43
1,583.16
1,468.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,312.79
1,130.16
1,122.48
1,069.50
1,117.43
1,583.16
1,468.34
Raw Material Cost
628.02
495.62
514.30
476.94
467.34
474.67
449.99
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
243.33
201.13
207.36
201.67
199.55
200.89
203.99
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.55
0.88
1.01
0.43
0.74
1.54
2.88
Selling and Distribution Expenses
483.33
411.62
431.65
453.58
533.47
800.95
759.99
Other Expenses
-12.67
-10.55
-10.93
-10.54
-13.38
-8.70
-11.98
Total Expenditure (Excl Depreciation)
1,231.58
1,003.70
1,044.99
1,027.26
1,067.30
1,391.06
1,297.08
Operating Profit (PBDIT) excl Other Income
81.19999999999999
126.5
77.5
42.199999999999996
50.099999999999994
192.10000000000002
171.29999999999998
Other Income
136.80
312.22
50.58
97.11
40.41
45.09
59.42
Operating Profit (PBDIT)
284.43
492.15
174.61
185.77
143.55
289.87
281.84
Interest
3.55
0.88
1.01
0.43
0.74
1.54
2.88
Exceptional Items
16.27
-14.77
0.55
-1.13
-59.95
-17.71
-8.28
Gross Profit (PBDT)
684.77
634.54
608.19
592.56
650.09
1,108.49
1,018.35
Depreciation
81.20
67.31
66.17
60.20
63.48
60.78
54.79
Profit Before Tax
215.95
409.19
107.99
124.01
19.38
209.85
215.89
Tax
29.99
58.39
24.76
15.01
22.32
28.66
29.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
184.53
361.83
93.61
122.11
8.62
188.14
184.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
184.53
361.83
93.61
122.11
8.62
188.14
184.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.43
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
185.96
361.83
93.61
122.11
8.62
188.14
184.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,769.92
4,903.43
4,349.38
4,410.51
4,302.10
4,416.85
4,569.92
Earnings per share (EPS)
0.72
1.41
0.37
0.48
0.03
0.74
0.72
Diluted Earnings per share
0.72
1.41
0.37
0.48
0.03
0.74
0.72
Operating Profit Margin (Excl OI)
5.06%
9.97%
5.15%
2.66%
3.55%
11.62%
11.42%
Gross Profit Margin
22.64%
42.16%
15.52%
17.22%
7.42%
17.09%
18.43%
PAT Margin
14.06%
32.02%
8.34%
11.42%
0.77%
11.88%
12.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 16.16% vs 0.69% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -48.59% vs 286.54% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -17.95% vs 45.08% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 300.00% vs -10.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Tianjin Lisheng Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,312.79
0
1,312.79
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,312.79
0
1,312.79
Raw Material Cost
628.02
0
628.02
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
243.33
0
243.33
Power Cost
0
0
0.00
Manufacturing Expenses
3.55
0
3.55
Selling and Distribution Expenses
483.33
0
483.33
Other Expenses
-12.67
0.00
-12.67
Total Expenditure (Excl Depreciation)
1,231.58
0
1,231.58
Operating Profit (PBDIT) excl Other Income
81.21
0.00
81.21
Other Income
136.80
0
136.80
Operating Profit (PBDIT)
284.43
0
284.43
Interest
3.55
0
3.55
Exceptional Items
16.27
0
16.27
Gross Profit (PBDT)
684.77
0
684.77
Depreciation
81.20
0
81.20
Profit Before Tax
215.95
0
215.95
Tax
29.99
0
29.99
Provisions and contingencies
0
0
0.00
Profit After Tax
184.53
0
184.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
184.53
0
184.53
Share in Profit of Associates
0
0
0.00
Minority Interest
1.43
0
1.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
185.96
0
185.96
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,769.92
0
4,769.92
Earnings per share (EPS)
0.72
0
0.72
Diluted Earnings per share
0.72
0
0.72
Operating Profit Margin (Excl OI)
5.06%
0%
0.00
5.06%
Gross Profit Margin
22.64%
0%
0.00
22.64%
PAT Margin
14.06%
0%
0.00
14.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 131.28 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.16% vs 0.69% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 18.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -48.59% vs 286.54% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.76 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -17.95% vs 45.08% in Dec 2023

Annual - Interest
Interest 0.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 300.00% vs -10.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.06%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023